• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Catalog Number ETLW1613C124EE
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 03/06/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that during an endovascular aortic repair with leia coiling for a 70 mm abdominal aortic aneurysm.The patient presented with hypertension, an angulated aortic neck (85 degrees) with bilateral common iliac aneurysm and a renal accessory artery on the right side a right renal accessory artery, intraluminal thrombus inside the abdominal aortic aneurysm sac and both common iliacaneurysms, and tortuous iliac arteries.During the procedure, a vascular plug was deployed on the left side, followed by implantation from the left side of the stent graft etbf2516c166e.E endur ii bif with side-by-side limb configuration.Multiple failed attempts at contralateral cannulation from right femoral access occurred, necessitating axial cannulation and snaring.During cannulation, the ipsilateral limb had not yet been fully deployed.After successful guidewire passage through the contralateral limb, the ipsilateral limb was fully deployed.The contralateral leg was extended with a device targeting the mid right common iliac artery for distal sealing, and the ipsilateral leg was extended to the left external iliac artery.Prior to angiography, the left external iliac artery was noted to have an accordion-like appearance.Balloon molding was performed on the proximal segment, overlapping graft, and both distal grafts.Aortography revealed no flow to both iliac arteries and a suspected thrombus inside the stents etlw1620c124ee & etlw1613c124ee with the thrombus extending to the main body.Thrombectomy was performed with several cycles on both sides.Final aortography showed restored contrast flow to both sides, with slow flow in the left iliac artery.The patient was transferred to the intensive care unit for observation and was reported to be alive and stable, extubated, and under observation post-procedure the cause was attributed to anatomy and turbulence flow from the tortuosity of the iliac arteries.
 
Additional Manufacturer Narrative
Film analysis conclusion : the reported stent graft occlusion was confirmed on review of the films provided.While the precise cause of the event cannot be definitively determined, anatomical factors , including tortuous iliac anatomy and the identified pre-operative vessel thrombus most likely contributed to the event.Other potential contributory factor, such as extension of the ipsilateral limb into the external iliac artery ,may have also played a role.The occlusive event may be also have been exacerbated by other conditions, e.G.An unknown coagulopathy that is now presenting, or a previous history of pad.Analysis of the returned films did not reveal any obvious out of specification stent graft integrity issues.Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: e tlw1620c124ee, serial/lot#: (b)(6), ubd: 12-nov-2027, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II ILIAC STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key24738732
Report Number9612164-2026-01632
Device Sequence Number17466401
Product Code MIH
UDI-Device Identifier00763000574949
UDI-Public(01)00763000574949(17)270923(20)01
Combination Product (Y/N)N
Initial Reporter CountryID
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/31/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberETLW1613C124EE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/23/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/12/2026
Initial Report FDA Received Date03/31/2026
Date Device Manufactured09/23/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
"SEE H11."
Outcome Attributed to Adverse Event Required Intervention;
Patient Age71 YR
Patient SexMale
-
-